CorEvitas LLC, a data intelligence company backed by Audax Private Equity, has acquired Pregistry LLC, which focuses on the safety of medications and vaccines used during pregnancy.

Founded in 2014, Pregistry utilizes the experience of over 70 pregnancy professionals covering a range of clinical, safety, regulatory, marketing and technology needs to provide information that supports healthy pregnancies and births. This investment aims to drive CorEvitas’ expansion of syndicated registries, complementing its base of experience in conducting post-approval safety studies in autoimmune and inflammatory-mediated diseases. The deal marks CorEvitas’ fifth acquisition and works to expand its evidence footprint to include syndicated pregnancy observational studies and retrospective claims studies.

“Now, with CorEvitas’ investment and partnership, our teams will be able to provide deeper clinical registry data, a holistic view of the pregnant person’s experience, and deeper resources to our customers,” comments Diego Wyszynski, founder and chief executive officer of Pregistry. “Pregnant people and healthcare providers will have access to more information, allowing better treatment decisions and healthier pregnancies and babies.”